Cancer screening in patients infected with HIV

被引:63
作者
Sigel K. [1 ]
Dubrow R. [2 ]
Silverberg M. [3 ]
Crothers K. [4 ]
Braithwaite S. [5 ]
Justice A. [6 ]
机构
[1] Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY 10029
[2] Yale School of Public Health, Yale School of Medicine, New Haven, CT
[3] Kaiser Permanente Northern California, Division of Research, Oakland, CA
[4] University of Washington School of Medicine, Seattle, WA
[5] New York University Langone Medical Center, New York, NY
[6] VA Connecticut Healthcare System, Yale University Schools of Medicine and Public Health, New Haven, CT
基金
美国国家卫生研究院;
关键词
Alpha-fetoprotein (AFP); Anal cancer; Anal cytology; Breast cancer; Cancer screening; Cervical cancer; Colonoscopy; Colorectal cancer; Combination antiretroviral therapy(cART); Digital rectal examination (DRE); Fecal occult blood testing (FOBT); Hepatocellular cancer; High-resolution anoscopy (HRA); Human immunodeficiency virus (HIV); Life-expectancy; Low-dose CT; Lung cancer; Mammography; Non-AIDS defining cancers (NADCs); Pap testing; Payoff time; Prostate cancer; Sigmoidoscopy; Ultrasonography;
D O I
10.1007/s11904-011-0085-5
中图分类号
学科分类号
摘要
Non-AIDS-defining cancers are a rising health concern among HIV-infected patients. Cancer screening isnow an important component of health maintenance in HIVclinical practice. The decision to screen an HIV-infectedpatient for cancer should include an assessment of individualizedrisk for the particular cancer, life expectancy, and theharms and benefits associated with the screening test and itspotential outcome. HIV-infected patients are at enhanced riskof several cancers compared to the general population; analcancer, hepatocellular carcinoma, Hodgkin's lymphoma, andlung cancer all have good evidence demonstrating anenhanced risk in HIV-infected persons. A number of cancerscreening interventions have shown benefit for specificcancers in the general population, but data on the application © Springer Science+Business Media, LLC 2011.
引用
收藏
页码:142 / 152
页数:10
相关论文
共 83 条
[1]  
Simard E.P., Engels E.A., Cancer as a cause of death among people with AIDS in the United States, Clin Infect Dis., 51, pp. 957-962, (2010)
[2]  
Lewden C., May T., Rosenthal E., Et al., Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalite 2000 and 2005" surveys (ANRS EN19 and Mortavic), J Acquir Immune Defic Syndr., 48, pp. 590-598, (2008)
[3]  
Phillips A.A., Justman J.E., Screening HIV-infected patients for non- AIDS-defining malignancies, Curr HIV/AIDS Rep., 6, pp. 83-92, (2009)
[4]  
Croswell J.M., Ransohoff D.F., Kramer B.S., Principles of cancer screening: Lessons from history and study design issues, Semin Oncol., 37, pp. 202-215, (2010)
[5]  
Braithwaite R.S., Fiellin D., Justice A.C., The payoff time: A flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines, Med Care., 47, pp. 610-617, (2009)
[6]  
Justice A.C., Prioritizing primary care in HIV: Comorbidity, toxicity, and demography, Top HIV Med., 14, pp. 159-163, (2006)
[7]  
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies, Lancet., 372, pp. 293-299, (2008)
[8]  
Losina E., Schackman B.R., Sadownik S.N., Et al., Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: Impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy, Clin Infect Dis., 49, pp. 1570-1578, (2009)
[9]  
Harrison K.M., Song R., Zhang X., Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States, J Acquir Immune Defic Syndr., 53, pp. 124-130, (2010)
[10]  
Green T.C., Kershaw T., Lin H., Et al., Patterns of drug use and abuse among aging adults with and without HIV: A latent class analysis of a US Veteran cohort, Drug Alcohol Depend., 110, pp. 208-220, (2010)